The isotope revolution that can change imaging and therapy

Similar documents
Isotope Production from Compact Neutron Sources. ~ 10 6 n/sec. Danish CANS workshop Mikael Jensen

Isotope Production for Nuclear Medicine

PRODUCTION OF RADIOISOTOPES FOR IMAGING AND THERAPY AT LOW ENERGY

Best MeV. Best , 25 MeV

Radiochemistry and Radiopharmacy III

RADIOPHARMACEUTICALS

Radiotracers for Early Diagnosis - ReSearching for a Better Life!

AEPHY: Nuclear Physics Practise Test

III. Proton-therapytherapy. Rome SB - 2/5 1

CLINICALLY USEFUL RADIONUCLIDES:

Bases of radioisotope diagnostic methods

Update from Karolinska

State Atomic Energy Corporation Rosatom Russian Radiation Technologies: opportunities to success

Low Energy Medical Isotope Production. Naomi Ratcliffe IIAA, University of Huddersfield UK

Year 12 Notes Radioactivity 1/5

Travels with a Cyclotron. David Parker University of Birmingham

Nuclear Medicine RADIOPHARMACEUTICAL CHEMISTRY

Some nuclei are unstable Become stable by ejecting excess energy and often a particle in the process Types of radiation particle - particle

Number of protons. 2. What is the nuclear symbol for a radioactive isotope of copper with a mass number of 60? A) Cu

PANEL DISCUSSION. Radionuclides and Health A promising future! OCTOBER 14-16, 2014 PARIS LE BOURGET FRANCE

RPR 29 CYCLOTRON RADIOCHEMISTRY LABORATORY

Positron Emission Tomography Dr. William C. Uhland Tyco-Mallinckrodt Pharmaceuticals, Maryland Heights, Missouri, USA

Nuclear Physics and Astrophysics

LIFTING HANDLE SUPPORT LUCITE TUBE GLASS COLUMN. VOLUME - 20 ml RETAINER. ALUMINA PACKING 10g (Al ) GLASS FRIT

Lecture Presentation. Chapter 21. Nuclear Chemistry. James F. Kirby Quinnipiac University Hamden, CT Pearson Education, Inc.

1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI)

Activation of Air and Concrete in Medical Isotope Production Cyclotron Facilities

Chapter 4: Radionuclide Production

Nuclear Chemistry. Chapter 23

Supervised assessment: Ionising radiation

Nuclear Chemistry. Background Radiation. Three-fourths of all exposure to radiation comes from background radiation.

NSAC Isotopes Subcommittee Meeting January 20, 2015 Erin Grady, MD Society of Nuclear Medicine and Molecular Imaging

Center for Design and Synthesis of Radiopharmaceuticals for Molecular Targeting CERAD on the Polish Roadmap for Research Infrastructures

Nuclear Medicine Treatments and Clinical Applications

Nuclear Medicine Intro & Physics from Medical Imaging Signals and Systems, Chapter 7, by Prince and Links

Differentiating Chemical Reactions from Nuclear Reactions

Radioisotopes and PET

AS to BS in Medical Dosimetry. Core Curriculum Course Descriptions

PET scan simulation. Meysam Dadgar. UMSU, Iran. IFMP, Elbasan, Fig 1: PET camera simulation in gate by cylindrical phantom

KIVI 9 Oct 2015 Fysische Beeldtechnieken 18 feb

[ 11 C]NNC 112 FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

The new BR2 Reactor Perspectives for Radioisotope Production

Applied Nuclear Physics at the NUS Physics Department

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

1) What is the reason that you have to isolate the daughter from the parent when the activity of the daughter reaches the maximum?

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy

Review A Z. a particle. proton. neutron. electron e -1. positron. e +1. Mass Number Atomic Number. Element Symbol

Medical Applications of Nuclear Radiation and Isotopes

LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator

Design specifications for compact cyclotrons

Cockcroft Institute Postgraduate Lectures: Applications of Accelerators. Production of Radioisotopes

RADIOCHEMICAL METHODS OF ANALYSIS

69 Ga Ga

Nuclear Radiation. Natural Radioactivity. A person working with radioisotopes wears protective clothing and gloves and stands behind a shield.

Outline Chapter 14 Nuclear Medicine

Physics in Nuclear Medicine

Lecture PowerPoints. Chapter 31 Physics: Principles with Applications, 7th edition Giancoli

PHY138Y Nuclear and Radiation Section

ICTP-IAEA Joint Workshop on Nuclear Data for Science and Technology: Medical Applications. 30 September - 4 October, 2013

Relevance of IsoDAR and DAEδALUS to Medical Radioisotope Production

Dosimetry of patients injected with tracers Ga-68, Zr-89 and Lu-177. Bruno Vanderlinden

EPFL SB - 2/4 1

12/1/17 OUTLINE KEY POINTS ELEMENTS WITH UNSTABLE NUCLEI Radioisotopes and Nuclear Reactions 16.2 Biological Effects of Nuclear Radiation

Physics of Novel Radiation Modalities Particles and Isotopes. Todd Pawlicki, Ph.D. UC San Diego

fission and fusion and classify a nuclear reaction as either a fission or fusion reaction.

General, Organic, and Biological Chemistry, 3e (Frost) Chapter 2 Atoms and Radioactivity. 2.1 Multiple-Choice

BG75 Plus [ 11 C] Upgrade CPM and Target Automated [ 11 C]Acetate Production & QC

MEDICAL RADIOISOTOPE PRODUCTION IN RESEARCH REACTORS

Management of Nuclear Knowledge: Applications of Nuclear Science

This Week. 3/23/2017 Physics 214 Summer

METHODS of RADIONUCLIDE PRODUCTION for MEDICAL ISOTOPE USABILITY

RECH-1 RESEARCH REACTOR: PRESENT AND FUTURE APPLICATIONS

Unit 12: Nuclear Chemistry

1. This question is about the Rutherford model of the atom.

Applications for Industry and Environment. Radioisotope and Radiation Technology. International Atomic Energy Agency

Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA ramsey

Introduction to SPECT & PET TBMI02 - Medical Image Analysis 2017

RADIOACTIVITY: spontaneous disintegration of the nucleus of certain atoms accompanied by the emission (release) of particles and/or energy

International Workshop PSD-11 Delft. Clive Naidoo (PhD Chemistry) Dept Head: Radionuclide Production ithemba LABS South Africa

Friday, 05/06/16 6) HW QUIZ MONDAY Learning Target (NEW)

Bioimage Informatics. Lecture 23, Spring Emerging Applications: Molecular Imaging

Chapter. Nuclear Chemistry

Simulations in Radiation Therapy

Simulation of photon-nuclear interaction in production of medical isotopes and transmutation of nuclear waste

C2-05: Creation of national standards for some emerging pharmaceutical radionuclides to ensure the radioprotection of patients and medical staffs

ESS and the UK share. Justin Greenhalgh Senior programme manager, UK-ESS

NUCLEAR MAGAZINE PROJECT QUESTIONS

Nuclear Chemistry. In this chapter we will look at two types of nuclear reactions.

Major Nuclear and Radiation Physics experimental facilities in. Prepared By Dr M Tanseer Ali

The Impact of Nuclear Science on Life Science. Introduction

Nuclear Chemistry. Radioactivity. In this chapter we will look at two types of nuclear reactions.

ACTIVATION ANALYSIS OF DECOMISSIONING OPERATIONS FOR RESEARCH REACTORS

Chapter 18. Nuclear Chemistry

NIST Standards in Nuclear Medicine. Essential Info When Dispensing Radioactive Material. Learning Objectives. Disclosures

Chapter 32 Applied Nucleonics

[ 11 C]MePPEP FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

TRIUMF TR13. Date form last updated: 2016 May 29. Completed by: David Prevost. 1. Cyclotron Facility Contact info. Institute (name/address):

Radiopharmaceuticals for Nuclear Cardiac Imaging: Generator Systems for Tc-99m and Rb-82. Charles W. Beasley, Ph.D. Associate Professor of Radiology

Nuclear Reactions A Z. Radioactivity, Spontaneous Decay: Nuclear Reaction, Induced Process: x + X Y + y + Q Q > 0. Exothermic Endothermic

6-4 Atomic structure Physics

Transcription:

The isotope revolution that can change imaging and therapy Mikael Jensen Professor of Applied Nuclear Physics The Hevesy Laboratory DTU Nutech, Technical University of Denmark George Hevesy

5.5 MeV protons 1938

I must confess that one reason we have undertaken this biological work is that we thereby have been able to get financial support for all of the work in the laboratory. As you know, it is much easier to get funds for medical research. Ernest Orlando Lawrence to Niels Bohr, 1935 Why should you trust a NUCLEAR PHYSICIST trying to change your mind on MEDICAL isotopes? There are no NEW isotopes, really?

Reason to listen: I am one of yours.made my first radiopharmaceutical 1975.. QP for 15 years..

Another reason to listen: Nuclear Medicine has developed greatly because of a push of technology from basic science and National Laboratories. Sadly, not often a pull from the medical side Radium and radon needles The cyclotrons The Manhattan programme Research reactors The Tc-99m generators F-18 and FDG The PET camera Sr-82 and Ge-68 from DOE facilities.. 5

6

PET-CT F-18 FDG T½ =110 min

Nuclear medicine can not work without isotopes. But what isotopes? Reasons to rethink the isotope supply : 1. The research reactor and Mo-99 situation 2. The development of PET-CT 3. The introduction of point-of demand cyclotrons 4. More NM procedures will be needed 5. Present supply chain can not meet global growth give me chance to elaborate before you throw the tomatoes 8

The Moly situation: 9

The Moly situation: 1957 1961 All Mo-99 made in Research Reactors 1961 1964 1957 Build and operated by public money 10

We know how to make new reactors, and we know how to make Mo-99 from LEU! But who s going to pay for the next generation of reactors and separation facilities? What s the price and construction time for a new set of research reactors? What s the price of waste management and facility decommissioning? it is not economically sustainable. 11

Not many reactors are needed. but there will be a reactor deficit unless policies and economics changes Bye, bye cheap neutrons and plentiful fission products 12

Do not panic OECD-NEA, August 2015 13

Do not panic. 14 But perhaps this IS panic?

Cyclotron Tc-99m is possible But it needs re-licensing, new dosimetry, New logistics, and... more money! 15

What s so good or special about Technetium? 16

The development in SPECT-CT and PET-CT The hardware in a BGO based low end PET system is not necessarily more expensive than a SPECT-CT system Tc-99m, I-123, In-111 F-18, Ga-68, Rb-82, C-11 17

Dosimetry!!? PET is always worse? Ga-68 versus Tc99m? A factor of 6 down in PHYSICAL T½ A factor of 10 up in deposited energy But we need less activity injected? 18 Lets go home and ask Olinda about the dose

What would it take to make Ga-68 labelled aggregated human albumin?? Would you see more in the picture? Would you need more examples? You will never get it approved! 19

Ga-68? From where? Ge-68 not easy to make. Very limited world wide supply 20 Obninsk Los Alamos and a few more

Ge-68 generator shortcomings: Price Limited time Limited number of elusions Eluate work-up often needed still, the generator is a wonderfull workhorse We just need more kit radiopharmaceuticals 21

Any small cyclotron can make you 30 GBq of Ga-68 in 1 hour! The solution targets are being developed just now! Cyclotrons will become Ga-68 generators solid targets are probably better.. 22

And Ga-68 yields itself well to chelation, late state labelling and kit chemistry Any good biovector But our cyclotrons can also do Ti-45 = good positron T½=3 hour workhorse Simple target, but needs new chelators! Ga-68 for the simple physological markers - lung and kidney 23

The table-top cyclotrons - or accelerators Bedside cyclotrons? Point-of-demand cyclotrons Many competing designs for 7-8 MeV protons on target- on its way ABT, GE Gentrace, Oniac.. more to come 24

The PT 600 prototype in place

What can we make with 7.8 MeV?

F-18 Small volume gridded Niobium target 10 um Havar, 7.4 MeV into water Grid of Aluminium Experimental experience 30uA 1.3 ml fill total volume 30 Bar overpressure With Argon At 35 ua on grid+ target: 30 = 9-12 GBq EOB 1 h = 20-23 GBq (n=15) 1 h beam, 25 min Fastlab synthesis = 16 GBq FDG EOS + 10 ^11 neutrons/ sec.. SO IT IS NOT a TABLETOP machine!

C-11 N-14 (p,alpha) C-11 This is where we need 7.8 MeV

N2+1%O2 gridded target C-11 as CO2 Experimental experience 135-150-200 psi 35 ua on target 30 ua into gas 30 minutes 12.2-15.0 GBq EOB(n=10) 60 minutes 22-26 GBq EOB (n=1) Specific activity measured by CO2+ Methane total in gas target empty : 4-20 Ci/umol C (150-740 GBq/umol) No labelled compounds yet

Now,- if we dream point of demand.. Why not, at last, do Clinical C-11? C-11 acetate C-11 methionine C-11 choline.. Will need better and deeper automation. Will need automatic QC Will ned new regulatory approach 30

Ga-68 Zn-68 electroplated on Silver 120 micrometer thick Run 60 mins at 30 ua 15 GBq Ga-68 @ EOB (n=2) who needs that? Tc99m replaced by Ga-68? The solution target is not useful at 7.8 MeV

The miniature cyclotron is part of a bigger dream The complete point of demand drug delivery system: Remember the shielding when you dream QC Chemistry Dispense Complete Computer Control Quality by design MTBF > 6 months

The integral hot cell Can we place and safely operate chemistry and radiopharmacy in a single confinement, with complete environmental control? In a otherwise non-descript facility? Can we make syntheis+dispensing + qc release completely automatic? Will it be accepted?

And then a word on therapy: I-131, Y-90, Lu-177 are here to stay. They NEED reactors. GOOD reactors But they can be transported on a global scale. For well targeted, internalised Auger electron emitters, a 13-19 MeV cyclotron can make enough activity for therapeutic patient doses: La-135,- existing chemistry ok Er-165,- existing chemistry ok Sb-119 new chemistry needed Ge-71 new chemistry needed 34 Still only a dream.

CONCLUSION: The real revolution: Radioisotopes for radiopharmaceuticals are made by cyclotrons, locally and only on demand. Well suited for global dissemination Preparing nuclear medicine for personalized medicine era ( = more scans!) Better diagnostic quality Industry will make money providing equipment, kits, starting materials. Only a few reactors will be needed The revolution isotopes: F-18 Ga-68 C-11 Ti-45 N-13 NH3? O-15 water What will it take: 35 More, new and better Chemistry Regulatory redefinition

36 Questions?